These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17914175)

  • 1. Optimizing expression of Streptococcus pneumoniae surface protein a, PspA: serocross-reactivity within families of antisera induced against clades 1 and 3.
    Silva M; Cabrera-Crespo J; Sbrogio-Almeida ME; Miyaji EN; Ho PL; Leite LC; Lopes AP
    Mol Biotechnol; 2007 Oct; 37(2):146-54. PubMed ID: 17914175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades.
    Darrieux M; Moreno AT; Ferreira DM; Pimenta FC; de Andrade ALSS; Lopes APY; Leite LCC; Miyaji EN
    J Med Microbiol; 2008 Mar; 57(Pt 3):273-278. PubMed ID: 18287288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational selection of broadly cross-reactive family 2 PspA molecules for inclusion in chimeric pneumococcal vaccines.
    Converso TR; Goulart C; Rodriguez D; Darrieux M; Leite LCC
    Microb Pathog; 2017 Aug; 109():233-238. PubMed ID: 28602840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
    da Silva MA; Converso TR; Gonçalves VM; Leite LCC; Tanizaki MM; Barazzone GC
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades.
    Miyaji EN; Ferreira DM; Lopes AP; Brandileone MC; Dias WO; Leite LC
    Infect Immun; 2002 Sep; 70(9):5086-90. PubMed ID: 12183557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS
    Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection.
    Moreno AT; Oliveira ML; Ferreira DM; Ho PL; Darrieux M; Leite LC; Ferreira JM; Pimenta FC; Andrade AL; Miyaji EN
    Clin Vaccine Immunol; 2010 Mar; 17(3):439-46. PubMed ID: 20089795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective properties of a fusion pneumococcal surface protein A (PspA) vaccine against pneumococcal challenge by five different PspA clades in mice.
    Piao Z; Akeda Y; Takeuchi D; Ishii KJ; Ubukata K; Briles DE; Tomono K; Oishi K
    Vaccine; 2014 Sep; 32(43):5607-13. PubMed ID: 25132335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pneumococcal vaccine combination with two proteins containing PspA families 1 and 2 can potentially protect against a wide range of Streptococcus pneumoniae strains.
    Yu J; Chen X; Li B; Gu T; Meng X; Kong W; Wu Y
    Immunol Res; 2018 Aug; 66(4):528-536. PubMed ID: 30128745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
    Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia.
    Brooks-Walter A; Briles DE; Hollingshead SK
    Infect Immun; 1999 Dec; 67(12):6533-42. PubMed ID: 10569772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses and protection against Streptococcus pneumoniae elicited by recombinant Bordetella pertussis adenylate cyclase (CyaA) carrying fragments of pneumococcal surface protein A, PspA.
    Carneiro GB; Castro JT; Davi M; Miyaji EN; Ladant D; Oliveira MLS
    Vaccine; 2023 Jun; 41(28):4170-4182. PubMed ID: 37236818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
    Lin H; Peng Y; Lin Z; Zhang S; Guo Y
    Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
    Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel method for production and purification of untagged pneumococcal surface protein A from clade 1.
    da Costa Rodrigues T; Zorzete P; Miyaji EN; Gonçalves VM
    Appl Microbiol Biotechnol; 2024 Apr; 108(1):281. PubMed ID: 38570417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-silico design and evaluation of an epitope-based serotype-independent promising vaccine candidate for highly cross-reactive regions of pneumococcal surface protein A.
    Afshari E; Cohan RA; Sotoodehnejadnematalahi F; Mousavi SF
    J Transl Med; 2023 Jan; 21(1):13. PubMed ID: 36627666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression, purification, and characterization of pneumococcal PsaA-PspA fusion protein.
    Guo X; Sun Q; Xi H; Zhang Y; Guo M; Zhang C; Zhu S; Gu T; Kong W; Wu Y
    Protein Expr Purif; 2021 Feb; 178():105782. PubMed ID: 33122039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
    Li B; Chen X; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Wu Y
    Microb Pathog; 2018 Oct; 123():115-119. PubMed ID: 29959043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model.
    Roche H; Håkansson A; Hollingshead SK; Briles DE
    Infect Immun; 2003 Mar; 71(3):1033-41. PubMed ID: 12595413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.
    Langermann S; Palaszynski SR; Burlein JE; Koenig S; Hanson MS; Briles DE; Stover CK
    J Exp Med; 1994 Dec; 180(6):2277-86. PubMed ID: 7964500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.